June 14, 2002
People with HIV who are younger than 50 may be at an increased risk of potentially fatal blood clotting, called venous thrombosis, suggests a study published in the May issue of AIDS Patient Care and STDs (2002;16:205-209). Although the scope of the problem needs to be examined further, the study alerts physicians who treat HIV patients to the risk of these blood clots, according to lead author Dr. Peter R. Smith of Long Island College Hospital in Brooklyn, New York.
Several years ago, if an HIV-positive person had shortness of breath and other signs of lung illness, Smith explained, a doctor would have considered the possibility that the person had pneumocystis carinii pneumonia or other common HIV-related infections. Based on the results of this study, it would be a good idea to consider a pulmonary embolism -- a blood clot in the lungs -- as the source of the respiratory symptoms, he said. Venous thromboembolism occurs when a blood clot or other blockage forms in the deep veins of the legs. If the clot breaks free and travels to the lungs, it may block an artery in the lungs, causing pulmonary embolism.
According to Smith, several case reports have suggested that there may be a relationship between HIV and an increased risk of venous thromboembolism. To test this connection, Smith and his colleagues reviewed the medical records of all patients with either HIV or venous thromboembolism who had been discharged from their hospital from July 1998 through June 1999. The study included 362 patients who were HIV-positive and 244 who had venous thromboembolism.
That younger HIV patients were more likely to have deep-vein clots is surprising, note the authors, since in the general population such clots tend to occur more frequently among older people. And even though younger individuals who have deep-vein thrombosis are more likely to be women than men, among the HIV-positive patients younger than 50, men were more likely to have the clots, the report indicates.
The reasons for the apparent increase in clotting risk among some people with HIV are uncertain, the investigators add. "We don't claim that it is the definitive study on the issue," said Smith. Still, he said that if physicians who treat people with HIV encounter a patient who has unexplained respiratory symptoms, "they should look for the possibility" of venous thromboembolism.
Adapted from:
Reuters Health
05.29.02; Merritt McKinney

This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.
|
|